Study to Improve Quality of Care and Patient Health in the Field of Cardiovascular Risk Factors in General Practice
Effects of a Series of Intensified Prevention Consultations on the Changes in Goals and Risk Factors in Hypertensive Patients at High Cardiovascular Risk
Sponsor: Assistance Publique - Hôpitaux de Paris
This PHASE4 trial investigates High Risk Hypertensive Patients and is currently completed. Assistance Publique - Hôpitaux de Paris leads this study, which shows 5 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Nov 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique - Hôpitaux de Paris
- Collège National des Généralistes Enseignants
- Institut National de la Santé Et de la Recherche Médicale, France
- Laboratoires Takeda
- Merck Serono International SA
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Lyon, France
- • Vincennes, France